STAT+: Pharmalittle: We’re reading about a Novartis gene therapy, faster U.K. drug reviews, and more

<iframe
  src="https://statesidedaily.com/embed/cluster/c36eadbaa0d6ca7e012678043afd537b1b3ec4a6"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about a Novartis gene therapy, faster U.K. drug reviews, and more"></iframe>